Even if the spectrum of genetic alterations in PCa is heterogeneous, these mutations are more frequently reported in the PI3K and MAPK pathways and in p53, RB and c-MYC genes, all known to affect tumorigenesis in a wide spectrum of tumors, while there are others genetic alterations more specifically reported in PCa [3]. This evidence concerns the gene PIK3CA and posterior cortical atrophy.